NASDAQ:INHX - Inhibitex Stock Price, Forecast & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Inhibitex LLC Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileEarningsFinancialsHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Inhibitex, Inc develops antibody-based products for the treatment and prevention of bacterial and fungal infections. The Company produces products that can be used as vaccines, binding inhibitors or separation supports for affinity purifications. The Company's lead product candidate, Veronate, which entered into Phase III clinical trial in the second half of 2004, is being developed for the prevention of hospital-associated infections in premature, very low birth weight, (VLBW) infants. Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryN/A SectorN/A Current SymbolNASDAQ:INHX Previous Symbol CUSIPN/A CIK1274913 Webhttp://www.inhibitex.com/ Phone+1-678-7461100Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive INHX News and Ratings via Email Sign-up to receive the latest news and ratings for INHX and its competitors with MarketBeat's FREE daily newsletter. Inhibitex (NASDAQ:INHX) Frequently Asked Questions What is Inhibitex's stock symbol? Inhibitex trades on the NASDAQ under the ticker symbol "INHX." Has Inhibitex been receiving favorable news coverage? Headlines about INHX stock have been trending extremely negative on Sunday, InfoTrie reports. The research group identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Inhibitex earned a news sentiment score of -4.5 on InfoTrie's scale. They also gave news coverage about the healthcare company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the near term. View News Stories for Inhibitex. What is Inhibitex's official website? The official website for Inhibitex is http://www.inhibitex.com/. How can I contact Inhibitex? Inhibitex's mailing address is 9005 Westside Pkwy, ALPHARETTA, GA 30009-4783, United States. The healthcare company can be reached via phone at +1-678-7461100. MarketBeat Community Rating for Inhibitex (NASDAQ INHX)Community Ranking: 2.8 out of 5 ( )Outperform Votes: 125 (Vote Outperform)Underperform Votes: 95 (Vote Underperform)Total Votes: 220MarketBeat's community ratings are surveys of what our community members think about Inhibitex and other stocks. Vote "Outperform" if you believe INHX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INHX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/26/2020 by MarketBeat.com StaffFeatured Article: How to start trading in the forex market?